Evidence map›Paper›PMID 32384822›Full record

ArticleViruses2020

Transcutaneous Administration of Dengue Vaccines.

Robert Andreata-Santos, Rúbens Prince Dos Santos Alves, Sara Araujo Pereira, Lennon Ramos Pereira, Carla Longo de Freitas, Samuel Santos Pereira, Alexia Adrianne Venceslau-Carvalho, Maria Fernanda Castro-Amarante, Marianna Teixeira Pinho Favaro, Camila Mathias-Santos and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Robert Andreata-SantosVaccine Development Laboratory, Microbiology Department, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.ORCID 0000-0002-4506-3756
Rúbens Prince Dos Santos AlvesVaccine Development Laboratory, Microbiology Department, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
Sara Araujo PereiraVaccine Development Laboratory, Microbiology Department, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
Lennon Ramos PereiraVaccine Development Laboratory, Microbiology Department, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
Carla Longo de FreitasVaccine Development Laboratory, Microbiology Department, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
Samuel Santos PereiraVaccine Development Laboratory, Microbiology Department, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
Alexia Adrianne Venceslau-CarvalhoVaccine Development Laboratory, Microbiology Department, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
Maria Fernanda Castro-AmaranteVaccine Development Laboratory, Microbiology Department, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.ORCID 0000-0003-2162-9505
Marianna Teixeira Pinho FavaroVaccine Development Laboratory, Microbiology Department, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
Camila Mathias-SantosVaccine Development Laboratory, Microbiology Department, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.
Jaime Henrique AmorimCenter for Biological and Health Sciences, Federal University of Western Bahia, Bahia 47810-047, Brazil.
Luís Carlos de Souza FerreiraVaccine Development Laboratory, Microbiology Department, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.ORCID 0000-0002-4883-1693
Universidade de São Paulo · BRUniversidade Federal do Oeste da Bahia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, we evaluated the immunological responses induced by dengue vaccines under experimental conditions after delivery via a transcutaneous (TC) route. Vaccines against type 2 Dengue virus particles (DENV2 New Guinea C (NGC) strain) combined with enterotoxigenic

Indexed as

Administration, CutaneousAnimalsAntibodies, ViralDengueDengue VaccinesDengue VirusHumansImmunizationImmunoglobulin GInjections, IntradermalMaleMiceMice, Inbred BALB CAntibodies, ViralDengue VaccinesImmunoglobulin Gadjuvantdengue vaccinesheat-labile toxinintradermic immunizationtranscutaneous immunization

Identifiers

PMID32384822
PMCPMC7290698
OpenAlexW3022659902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.